Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Thiele
Observed names:
M Thiele,
M. Thiele,
Thiele, Michael
Institution:
TU Wien
Observed institutions:
TU Wien,
Amsterdam UMC Location University of Amsterdam,
Yale University,
Baxter (Austria),
Universitätsklinikum Aachen,
Takeda (Austria),
Medical University of Vienna,
RWTH Aachen University
show all 8
ORCID:
0000-0002-3003-9999
Observed ORCID:
0000-0002-3003-9999
OpenAlex ID:
A5045242452
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
2007
·
H Lue
, M Thiele
, et al.
·
Oncogene
·
427
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity
2005
·
Hongqi Lue
, Aphrodite Kapurniotu
, et al.
·
Cellular Signalling
·
237
Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice
2003
·
Andreas Schober
, Jürgen Bernhagen
, et al.
·
Circulation
·
190
PDF
The Cytokine Macrophage Migration Inhibitory Factor Reduces Pro-Oxidative Stress-Induced Apoptosis
2003
·
Mai Tuyet Nguyen
, Hongqi Lue
, et al.
·
The Journal of Immunology
·
150
PDF
Link Between Macrophage Migration Inhibitory Factor and Cellular Redox Regulation
2005
·
Michael Thiele
, Jürgen Bernhagen
·
Antioxidants and Redox Signaling
·
110
Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo
2013
·
Filza Hussain
, Michael Freissmuth
, et al.
·
Molecular Cancer Therapeutics
·
76
Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF
2012
·
Randolf J. Kerschbaumer
, Manfred Rieger
, et al.
·
Journal of Biological Chemistry
·
65
OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
2022
·
Michael Thiele
, Seamas C Donnelly
, et al.
·
Journal for ImmunoTherapy of Cancer
·
63
PDF
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions
2015
·
Michael Thiele
, Randolf J Kerschbaumer
, et al.
·
The Journal of Immunology
·
62
PDF
Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif
2005
·
Anke Burger-Kentischer
, Doris Finkelmeier
, et al.
·
FEBS Letters
·
58
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer
2016
·
Alexander Schinagl
, Michael Thiele
, et al.
·
Oncotarget
·
45
PDF
Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch
2018
·
Alexander Schinagl
, Randolf J. Kerschbaumer
, et al.
·
Biochemistry
·
33
Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic
2023
·
Gregor Rossmueller
, Irina Mirkina
, et al.
·
Molecular Cancer Therapeutics
·
18
PDF
Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics
2019
·
Patrice Douillard
, Michael Freissmuth
, et al.
·
Antibodies
·
10
PDF
Redox-dependent plasticity of oxMIF facilitates its interaction with CD74 and therapeutic antibodies
2024
·
Sara Sajko
, Erin Skeens
, et al.
·
Redox Biology
·
9
The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis
2023
·
Maroua Ferhat
, Katia Mangano
, et al.
·
European Journal of Pharmacology
·
9
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis
2017
·
Werner Höllriegl
, Alexander Bauer
, et al.
·
European Journal of Pharmacology
·
8
Pretargeted Radioimmunotherapy with the Novel Anti-oxMIF/HSG Bispecific Antibody ON105 Results in Significant Tumor Regression in Murine Models of Cancer
2024
·
Alejandro A. Puchol Tarazona
, Alexander Schinagl
, et al.
·
Molecular Cancer Therapeutics
·
4
Abstract 2974: Targeting the oxidized form of macrophage migration inhibitory factor (oxMIF) with antibody ON203 activates the tumor microenvironment
2023
·
Barbara Maurer
, Eric R. Haas
, et al.
·
Cancer Research
·
3
Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis
2024
·
Maroua Ferhat
, Julia Mayer
, et al.
·
PLoS ONE
·
2
Abstract A153: Imalumab, a first-in-class anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody penetrates tumor tissues and shows antitumor activity in patients
2015
·
Patrice Douillard
, Michael Thiele
, et al.
·
Molecular Cancer Therapeutics
·
2
Abstract 4841: Oxidized macrophage migration inhibitory factor (oxMIF) expressed by tumor stroma and tumor cells, contributes to tumor growth
2014
·
Alexander Schinagl
, Thorsten Hagemann
, et al.
·
Cancer Research
·
2
Abstract 313: Novel bioengineered monoclonal antibodies targeting oxidized macrophage migration inhibitory factor as anti-cancer therapeutics and companion diagnostics
2022
·
Alexander Schinagl
, Michael Thiele
, et al.
·
Cancer Research
·
1
A fully human anti-oxMIF antibody penetrates colorectal cancer metastases and accumulates in cancer tissue
2015
·
M. Thiele
, A. Schinagl
, et al.
·
Annals of Oncology
·
1
811: Fully human antibodies specific for oxidized macrophage migration inhibitory factor (oxMIF) exhibit anti-cancer activity in animal models
2014
·
M. Thiele
, T. Hagemann
, et al.
·
European Journal of Cancer
·
1
Show more works
View as search
Works count:
86
Citation count:
1,587
H-index:
13
I10-index:
14
Year
Topic
Type